Moderna Could Have Omicron Booster Shot Ready to File for FDA Authorization by March

Moderna Could Have Omicron Booster Shot Ready to File for FDA Authorization by March
Three vials of the Moderna COVID-19 Vaccine are pictured on Feb. 17, 2021. Michael Sohn/AP Photo
|Updated:

Moderna President Stephen Hoge said Wednesday that the company could have a COVID-19 booster shot to combat the newly-discovered Omicron variant tested and ready to file for U.S. authorization as soon as March.

Boosters carrying genes specifically to combat mutations in the variant could be the quickest way to address any effect it may have on the potency of vaccines, Hoge told Reuters.

Katabella Roberts
Katabella Roberts
Author
Katabella Roberts is a news writer for The Epoch Times, focusing primarily on the United States, world, and business news.
Related Topics